Search results
Reduced Breast Cancer Mortality: Screen, Prevent, Treat
Medscape· 3 days agoDr Maurie Markman discusses results from a modeling study investigating the reduction in breast...
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 19 hours agoRecently the FTC sent letters almost identical in substantive import to ten major drug companies (Amphaster Pharma, Covis Pharma, Novartis, Norton (Waterford) Ltd., GlaxoSmithKline& ...
Drugmaker Abbott India posts Q4 profit rise on higher sales
Reuters via Yahoo News· 7 days agoRevenues of drugmakers such as Abbott India and GlaxoSmithKline Pharma India, which get most of...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 3 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Extended Imatinib Maintenance Boosts Disease-Free Survival in High-Risk GIST
MedPage Today· 6 days agoPatients with high-risk gastrointestinal stromal tumors (GISTs) had a 60% improvement in 3-year...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 5 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
NowVertical Group Inc (NOWVF) Q4 2023 Earnings Call Transcript Highlights: Impressive Growth ...
GuruFocus.com via Yahoo Finance· 7 days agoNowVertical Group Inc has a robust client portfolio with over 250 clients, including 100+ key accounts with major enterprises like Sky, Disney, and GlaxoSmithKline, indicating ...
Managing Comorbidities in Chronic Urticaria
MedPage Today· 7 days agoThe link between chronic urticaria and atopic diseases, autoimmune diseases, and psychiatric disorders has significant implications for clinical practice. Managing comorbidities is key to optimizing ...
'Patients are Waiting'
Pharmaceutical Executive Magazine· 2 days agoFor 2024, that esteemed honor went to Yvonne Greenstreet, CEO of Alnylam. In early January, the HBA announced the longtime executive, who, notably, has...
